Imprimis NJOF, LLC recalls Prednisolone Sodium Phosphate-Moxifloxacin-Bromfenac Sterile Ophthalmic Solution 1%, 0.5%, 0.075%, 8mL, Compounded By: Imprimis NJOF, LLC.…
Subpotent Drug
Read the official notice →- Date
- 2024-05-08
- Country
- United States
- Brand
- Imprimis NJOF
- Product
- Prednisolone Sodium Phosphate-Moxifloxacin-Bromfenac Sterile Ophthalmic Solution 1%, 0.5%, 0.075%, 8mL, Compounded By: Imprimis NJOF, LLC.…
- Classification
- Class II
- Units
- U.S. Nationwide
- Category
- Drugs & medical
- Source
- FDA · Drug
Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer
What to do
- Check the product name, strength and lot number against the official notice.
- Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
- Ask the pharmacy or supplier about a replacement or refund.
General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.
More Imprimis NJOF recalls
- 2024-06-19
US- 2024-06-05
- US
- 2024-05-08
- US
- 2023-10-25
- US
Imprimis NJOF, LLC recalls MYDRIATIC-4: Tropicamide - Proparacaine - Phenylephrine - Ketorolac Sterile Ophthalmic Solution Drops 1% - 0.5% - 2.5% - 0.5%, 5mL bottle,…
Subpotent: Out of Specification result observed for Ketorolac assay levels, below the 90.0-110.0% of label claim.
FDA · DrugImprimis NJOF, LLCProduct was distributed to physician's offices nationwide.Official notice → - 2023-10-11
- US
Imprimis NJOF, LLC recalls Epinephrine-Lidocaine HCl (0.25mg/mL and 7.5mg/mL) 1mL Single Use Intraocular injection Preservative Free NDC 71384-640-01 Not for resale.…
Subpotent: Failing Test Results for Epinephrine
- 2023-08-30
- US
Imprimis NJOF, LLC recalls Moxifloxacin - Bromfenac Sterile Ophthalmic Solution 0.5% / 0.075%, 5mL bottle, Imprimis NJOF, LLC. 1705 Route 46 West, Unit 6B,…
Subpotent Drug; sub-potent Bromfenac levels, below the 90.0-110.0% specification range.
Other drugs & medical recalls in the United States
- 2024-05-08
- US
Regeneron Pharmaceuticals Inc recalls EYLEA, (aflibercept) Injection, 2 mg (0.05mL of a 40mg/mL solution), Single-dose Pre-filled Syringe, Rx only, Manufactured by:…
Lack of Assurance of Sterility: Complaints of syringe breakage
- US
- US
- 2024-05-01
- US
Philips North America Llc recalls Philips Patient Information Center (PIC) iX Uninterruptable Power Supply (UPS): 1. APC (Schneider Electric IT Corporation) 120V…
Possible failure of Uninterruptable Power Supply (UPS) devices supporting the Patient Information Center (PIC) iX system, potential for the associated PIC iX system to shut down due to the lack of power. may lead to…
FDA · DevicePhilips North America LlcWorldwide distribution - US Nationwide and the countries of Argentina, Aruba,…Official notice → - US
Baxter Healthcare Corporation recalls Baxter Seprafilm Adhesion Barrier 1 Half Sheet, 5-PK, REF 664103, for use in abdominal and pelvic surgery
Product was distributed in the United States without proper regulatory approval.
FDA · DeviceBaxter Healthcare CorporationUS Nationwide distribution in the states of LA, GA, IN, VA FL, NY, CA.Official notice → - US
Electro Medical Systems SA recalls Brand Name: WATER BOTTLE Product Name: WATER BOTTLE Model/Catalog Number: EG-121 Software Version: N/A Product Description: These…
Received complaints that bottles assembled with one batch of bottle collars can be disassembled in two parts when used under pressure (during treatment or storage if the use is not releasing the pressure inside the…
FDA · DeviceElectro Medical Systems SAWorldwide distribution - U.S. Nationwide in the states of IL and TX. The…Official notice →